rs386833987
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_012434.5(SLC17A5):c.1007_1008delTA(p.Leu336TrpfsTer14) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,504 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_012434.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151738Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461766Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 727190
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151738Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74048
ClinVar
Submissions by phenotype
Salla disease Pathogenic:3
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 56551). This premature translational stop signal has been observed in individual(s) with SLC17A5-related conditions (PMID: 10947946). This variant is present in population databases (rs386833987, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Leu336Trpfs*14) in the SLC17A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC17A5 are known to be pathogenic (PMID: 10581036, 10947946, 15172001). -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at